Cytokinetics, Incorporated (CYTK)

NASDAQ: CYTK · Real-Time Price · USD

30.00

-0.61 (-1.99%)

At close: May 14, 2025, 4:00 PM

30.45

+0.45 (1.50%)

After-hours: May 14, 2025, 7:59 PM EDT

Cytokinetics Market Cap

Cytokinetics has a market cap or net worth of $3.58 billion as of May 14, 2025. Its market cap has decreased by -46.77% in one year.

Market Cap

3.58B

Enterprise Value

3.57B

1-Year Change

-46.77%

Ranking

#1489

Market Cap Chart

Since April 30, 2004, Cytokinetics's market cap has increased from $419.30M to $3.58B, an increase of 754.48%. That is a compound annual growth rate of 10.73%.

Market Cap History

Date	Market Cap	% Change
May 13, 2025	3.66B	-34.15%
Dec 31, 2024	5.55B	-32.19%
Dec 29, 2023	8.19B	88.80%
Dec 30, 2022	4.34B	13.41%
Dec 31, 2021	3.82B	159.95%
Dec 31, 2020	1.47B	134.61%
Dec 31, 2019	626.90M	81.29%
Dec 31, 2018	345.80M	-21.27%
Dec 29, 2017	439.20M	-10.79%
Dec 30, 2016	492.30M	21.17%
Dec 31, 2015	406.30M	38.57%
Dec 31, 2014	293.20M	52.87%
Dec 31, 2013	191.80M	104.04%
Dec 31, 2012	94.00M	35.45%
Dec 30, 2011	69.40M	-49.60%
Dec 31, 2010	137.70M	-22.34%
Dec 31, 2009	177.30M	25.83%
Dec 31, 2008	140.90M	-39.40%
Dec 31, 2007	232.50M	-17.84%
Dec 29, 2006	283.00M	51.01%
Dec 30, 2005	187.40M	-35.49%
Dec 31, 2004	290.50M	-30.72%

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	669.76B
Johnson & Johnson	357.16B
AbbVie	332.08B
Novo Nordisk	291.59B
UnitedHealth Group	282.47B
Abbott Laboratories	224.53B
Novartis AG	209.81B
AstraZeneca	209.59B

Market Cap Rankings